
|Articles|December 1, 2003
- Pharmaceutical Executive-12-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
Predicting Success: A Pipeline Reportover 22 years ago
Interferons: A Family BusinessAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Focusing on Asset Acquisition Over Building a Single Platform Technology
5




